Core Viewpoint - Jin Xin Kang Yang is preparing for an IPO on the Hong Kong Stock Exchange, reflecting the trend of institutional elder care moving towards scale, standardization, and capitalization in the context of China's aging population [2][8]. Company Overview - Jin Xin Kang Yang is a leading player in the private elder care sector in China, focusing on the integration of medical and elder care services, primarily targeting elderly individuals aged 80 and above with urgent care needs [2][3]. - The company has established or acquired 23 medical-elder care facilities, expanding its operations from the Sichuan-Chongqing region to key economic areas like the Yangtze River Delta and the Greater Bay Area [3]. Financial Performance - In 2023, Jin Xin Kang Yang reported a revenue of 489 million yuan, with a projected growth of 23.7% to 605 million yuan in 2024. For the first nine months of 2025, the revenue reached approximately 547 million yuan, marking a 22.1% increase compared to the same period in 2024 [3]. - The company's gross margin was 21.7% in 2023, expected to rise to 23.3% in 2024, and 22.5% in the first nine months of 2025, significantly higher than the industry average of below 20% [3]. - Despite revenue growth, the company faced challenges with profitability, reporting a profit of 27.06 million yuan in 2023, which is projected to increase to 40.31 million yuan in 2024 but dropped to 26.11 million yuan in the first nine months of 2025, indicating cash flow and profitability balance challenges [3]. Market Opportunity - The aging population in China is creating a substantial demand for elder care services, with projections indicating that by the end of 2025, there will be 320 million individuals aged 60 and above, accounting for 23% of the total population [5]. - The institutional elder care market in China is expected to grow from 133.4 billion yuan in 2024 to 189.4 billion yuan by 2030, with a compound annual growth rate of 6.0% from 2024 to 2030 [5]. Industry Challenges - The elder care industry is highly fragmented and competitive, with over 1.25 million existing enterprises, predominantly small and micro businesses, leading to challenges in profitability and service standardization [6]. - The industry faces issues such as unclear profit models, a shortage of professional talent, and uneven regional development, which hinder the overall maturity of the supply side [6]. Regulatory Environment - The industry is under scrutiny, as evidenced by penalties faced by major players like Jin Xin Kang Yang for regulatory violations, highlighting the need for stronger oversight in the sector [6]. Future Outlook - If Jin Xin Kang Yang successfully completes its IPO, it could signify a pivotal shift towards a more standardized and capitalized elder care industry, enhancing quality and resource integration [8].

Group 1 - The core point of the article is that Jin Xin Kang Yang Industrial Group Co., Ltd. has submitted an application for listing on the Hong Kong Stock Exchange, marking another Chengdu enterprise's move towards capital market engagement [1][2] - Jin Xin Kang Yang is headquartered in Chengdu and is the second company from Jin Xin Group to enter the capital market, following Jin Xin Reproductive [1] - The main business of Jin Xin Kang Yang includes the operation of health and wellness communities and integrated medical and elderly care services, aiming to provide high-quality elderly care services [1] Group 2 - As of September 30, 2025, Jin Xin Kang Yang has established or acquired 23 integrated medical and elderly care facilities, enabling comprehensive medical and elderly care services [1] - The company ranks first in China's institutional elderly care service industry in terms of the proportion of elderly residents with mobility impairments and occupancy rates of integrated medical and elderly care facilities, with an 85% share [1] - In the Chengdu-Chongqing region, Jin Xin Kang Yang leads in the number of integrated medical and elderly care facilities and beds among professional private chain enterprises [1][2] Group 3 - Chengdu is actively promoting enterprises to connect with capital markets, exemplified by Jin Xin Kang Yang's listing application [2] - The Chengdu Financial Office plans to implement the "Rong Yi Shang" full lifecycle service for enterprise listings, leveraging various local financial resources and initiatives to accelerate the listing of quality enterprises domestically and internationally [2]

Core Viewpoint - Sichuan-based Jin Xin Kang Yang Industrial Group Co., Ltd. has submitted its application for a mainboard listing on the Hong Kong Stock Exchange, aiming to become a representative enterprise in the medical and elderly care sector in Sichuan [1][4]. Group 1: Company Overview - Jin Xin Kang Yang focuses on a "medical and elderly care" model, targeting the elderly population over 80 years old, particularly those with mobility issues, chronic diseases, or cognitive impairments [4]. - The company has established or acquired 23 medical and elderly care facilities, operating a total of 38 facilities, expanding its business from Sichuan to the Yangtze River Delta and the Guangdong-Hong Kong-Macao Greater Bay Area [4]. Group 2: Market Potential - The Chinese institutional elderly care service market is projected to grow from 133.4 billion yuan in 2024 to 189.4 billion yuan by 2030, with a compound annual growth rate (CAGR) of 6% [5]. - By 2035, the market size is expected to reach 228.2 billion yuan, with a CAGR of 3.8% from 2030 to 2035, providing a strong foundation for Jin Xin Kang Yang's IPO ambitions [6]. Group 3: Financial Performance - Jin Xin Kang Yang's revenue has shown steady growth, increasing from 489 million yuan in 2023 to 605 million yuan in 2024, representing a year-on-year growth of 23.8% [7]. - For the first nine months of 2025, the company reported revenue of 547 million yuan, a 22% increase compared to the same period last year [7]. - However, profitability has fluctuated, with net profit for 2024 at 40.31 million yuan, a 48.9% increase, but dropping to 26.11 million yuan in the first nine months of 2025, a decline of approximately 31% [7]. Group 4: Industry Challenges - The elderly care industry faces significant challenges, including a high dependency on a few suppliers, with the top five suppliers accounting for 44.1% of purchases by 2025, which may affect supply chain stability [8]. - The industry is characterized by a severe shortage of qualified professionals, with a caregiver shortage rate of approximately 96%, impacting the operational capabilities of companies like Jin Xin Kang Yang [9]. - The company is implementing initiatives such as the "Spark Plan" and "1+4 Elite Model" to address talent retention, managing to keep its caregiver turnover rate at 20%, below the industry average of 40%-50% [9].

Group 1 - Jinxin Healthcare Industry Group Limited has submitted its listing application to the Hong Kong Stock Exchange, with CICC and GF Securities as joint sponsors [1][2] - The company is headquartered in Chengdu and focuses on the operation of healthcare communities and integrated medical care services, being part of the Jinxin Group [3] - Jinxin Healthcare ranks first in the institutional elderly care service industry in China, with an 85% occupancy rate for action-disabled elderly residents and leading in the number of integrated medical care facilities in the Sichuan-Chongqing region [3] Group 2 - The company reported revenues of approximately RMB 489 million, RMB 605 million, and RMB 547 million for the nine months ending September 30 in 2023, 2024, and 2025 respectively, with corresponding profits of RMB 27.06 million, RMB 40.31 million, and RMB 26.11 million [3] - The gross profit margins for the same periods were 21.7%, 23.3%, and 22.5% respectively [3] - Jinxin Healthcare has completed multiple rounds of equity financing since 2017, with investors including OrbiMed and Sichuan Health Care Investment [6] Group 3 - Other Sichuan enterprises, such as Jiuxin Technology and Chengdu Hehong Technology, are also in the process of listing guidance, indicating a vibrant capital market in Sichuan [1][10] - Jiuxin Technology has completed its listing guidance registration with the Sichuan Securities Regulatory Bureau, while Hehong Technology has also registered for its IPO guidance [9][11]

Core Viewpoint - The aging process in China is leading the institutional elderly care industry to transition from "scale expansion" to "quality cultivation," with Jin Xin Kang Yang's IPO marking a significant step in this evolution and serving as a model for high-quality development in the sector [1][9]. Industry Overview - The Chinese institutional elderly care service market is projected to reach CNY 133.4 billion in 2024, with expectations to grow to CNY 189.4 billion by 2030 and further to CNY 228.2 billion by 2035, despite a slowdown in growth rate [2][9]. - The average occupancy rate of elderly care institutions in China is only 45%, with a nearly 90% shortfall in required nursing beds, highlighting a significant gap in services for the elderly, particularly those with urgent needs [2][9]. Company Positioning - Jin Xin Kang Yang focuses on the needs of elderly individuals over 80 years old, particularly those with mobility issues, chronic diseases, and cognitive impairments, establishing a deep integration of medical and elderly care services [2][9]. - As a leader in the industry, Jin Xin Kang Yang holds the top position in several key metrics, including the proportion of elderly residents with mobility impairments and the occupancy rate of integrated medical and elderly care facilities [2][11]. Service Model - The company has developed a comprehensive service network that includes 23 integrated medical and elderly care facilities across key regions such as Sichuan-Chongqing, the Yangtze River Delta, and the Greater Bay Area [4][13]. - Jin Xin Kang Yang's service model emphasizes a shift from a "disease-centered" approach to one that meets the holistic needs of elderly individuals, ensuring continuity of care through partnerships with nearby hospitals [4][13]. Financial Performance - Jin Xin Kang Yang's revenue grew from CNY 488.5 million in 2023 to CNY 604.8 million in 2024, reflecting a growth rate of 23.8%, with a further increase to CNY 547.2 million in the first nine months of 2025 [7][16]. - The company's gross profit rose from CNY 106.0 million in 2023 to CNY 141.0 million in 2024, with a gross profit margin consistently above 20% [7][16]. IPO Plans - The funds raised from the IPO will be allocated to expanding the elderly care facility network, enhancing operational capabilities, increasing brand awareness, and supplementing working capital [8][16]. - The listing is expected to set a benchmark for private elderly care enterprises and drive the industry towards a model of integrated medical and elderly care [9][18].

Company Overview - Jinxin Healthcare Industry Group Limited has submitted a listing application to the Hong Kong Stock Exchange, with China International Capital Corporation and GF Securities as joint sponsors [1] - The company is a leader in China's rapidly growing institutional elderly care service market, focusing on providing integrated medical and elderly care services to seniors aged 80 and above and those with urgent care needs [1] Market Position - As of September 30, 2025, Jinxin Healthcare ranks first among all major players in China's institutional elderly care service industry, with an 85% market share in both the proportion of elderly residents with mobility impairments and the occupancy rate of integrated medical and elderly care facilities [3] - The company also ranks first among private chain elderly care enterprises in China in terms of the number of integrated medical and elderly care facilities and beds in the Sichuan-Chongqing region [3] - Jinxin Healthcare has established or acquired 23 integrated medical and elderly care facilities, covering the Sichuan-Chongqing region, Yangtze River Delta, and Greater Bay Area [3] Services Offered - The company provides a comprehensive range of elderly care services, including housing, professional nursing and care services, nutritional management, social and cultural entertainment services, medical services, rehabilitation and assistance services, and on-demand services [4] Financial Performance - For the fiscal year ending December 31, 2023, the company reported revenues of approximately RMB 488.5 million, with a gross profit of RMB 106.0 million and a net profit of RMB 27.1 million [6][8] - Revenue is projected to increase to RMB 604.8 million in 2024 and RMB 547.0 million for the nine months ending September 30, 2025 [7] - The gross profit margin for 2023, 2024, and the nine months ending September 30, 2025, is reported at 21.7%, 23.3%, and 22.5%, respectively [10] Industry Overview - The elderly care industry in China is driven by significant demographic changes, with the population aged 65 and above growing at a compound annual growth rate (CAGR) of 3.9% from 2020 to 2024, and the population aged 80 and above growing at a CAGR of 5.1% [11] - The market size of the elderly care industry in China is expected to grow from RMB 7.4 trillion in 2020 to RMB 14.1 trillion in 2024, representing a CAGR of 17.5% [16]

Company Overview - Jinxin Kangyang Industrial Group Limited has submitted a listing application to the Hong Kong Stock Exchange, with CICC and GF Securities as joint sponsors. The company is a leader in China's rapidly growing institutional elderly care service market, focusing on providing integrated medical and elderly care services to seniors aged 80 and above and those with urgent care needs [1][3]. - As of September 30, 2025, Jinxin Kangyang ranks first among all major players in China's institutional elderly care service industry, with an 85% market share in both the proportion of elderly residents with mobility impairments and the occupancy rate of integrated medical and elderly care facilities [3]. Services Offered - The company provides a comprehensive range of elderly care services, including housing, professional nursing and care services, nutritional management, social and cultural entertainment services, medical services, rehabilitation and assistance services, and on-demand services. Its medical services are delivered through a network of elderly care facilities, geriatric hospitals, psychiatric hospitals, traditional Chinese medicine hospitals, and general hospitals [4]. Financial Performance - For the nine months ending September 30 in 2023, 2024, and 2025, the company reported revenues of approximately RMB 489 million, RMB 605 million, and RMB 547 million, respectively. The net profits for the same periods were RMB 27.06 million, RMB 40.31 million, and RMB 26.11 million [5]. - The gross profit margins for the same periods were 21.7%, 23.3%, and 22.5%, respectively [7]. Industry Overview - The development of China's elderly care industry is driven by significant demographic changes, with the population aged 65 and above growing at a compound annual growth rate (CAGR) of 3.9% from 2020 to 2024, and the population aged 80 and above growing at a CAGR of 5.1%. By 2024, the population aged 80 and above is expected to reach 43.7 million, increasing to 79 million by 2035 [8][13]. - The market size of China's elderly care industry is projected to grow from RMB 7.4 trillion in 2020 to RMB 14.1 trillion in 2024, with a CAGR of 17.5%. By 2030, it is expected to reach RMB 31.7 trillion, and by 2035, RMB 46.6 trillion, with a CAGR of 8.0% [13].